Activated cdc42-associated kinase is up-regulated in non-small-cell lung cancer and necessary for FGFR-mediated AKT

Fengqing Hu1, Hongcheng Liu2, Xiao Xie1

  • 1Department of Cardiothoracic Surgery, Xinhua Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China.

Insights

Activated CDC42-associated tyrosine kinase 1 (ACK1) promotes non-small-cell lung cancer (NSCLC) growth, migration, and metastasis. Upregulated ACK1 expression correlates with poor survival, suggesting it as a potential therapeutic target for NSCLC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Activated CDC42-associated tyrosine kinase 1 (ACK1) is implicated in non-small-cell lung cancer (NSCLC).
  • The precise role and expression patterns of ACK1 in NSCLC progression remain incompletely elucidated.
  • Understanding ACK1's function is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the expression profile of ACK1 in NSCLC tissues.
  • To determine the biological functions of ACK1 in NSCLC cell growth, migration, and metastasis.
  • To elucidate the molecular mechanism underlying ACK1's role in NSCLC progression.

Main Methods:

  • Quantitative analysis of ACK1 expression in NSCLC and adjacent normal tissues.
  • In vitro and in vivo assays to assess the impact of ACK1 on NSCLC cell behavior.
  • Western blot analysis to examine protein interactions and phosphorylation states, specifically focusing on FGFR1, AKT, and FGF signaling pathways.

Main Results:

  • ACK1 expression was significantly upregulated in NSCLC samples compared to normal tissues.
  • ACK1 expression levels were inversely correlated with patient survival rates.
  • ACK1 overexpression promoted NSCLC cell growth, migration, and metastasis in vitro and in vivo.
  • ACK1 was found to bind with FGFR1 and mediate FGF-induced AKT phosphorylation.

Conclusions:

  • ACK1 plays a significant oncogenic role in the progression of non-small-cell lung cancer.
  • ACK1 promotes tumor growth, migration, and metastasis through interaction with FGFR1 and regulation of AKT signaling.
  • ACK1 represents a promising therapeutic target for the treatment of NSCLC.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.4K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
8.0K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
19.6K